Could a daily cannabinoid pill shield Athletes' brains from concussion?

NCT ID NCT07715864

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study tests whether a daily broad-spectrum cannabinoid capsule can protect the brain and speed recovery from concussion in healthy male athletes who play contact sports. Participants take either the active capsule or a placebo twice daily, and researchers measure brain blood flow, inflammation markers, and concussion rates. The goal is to see if this natural compound can reduce injury and support brain health during high-impact competition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a broad-spectrum cannabinoid formulation in a gel capsule
What this could lead to
If it works, this could point toward a daily supplement that reduces concussion risk and speeds brain recovery in contact-sport athletes.
What could go wrong
This is a small early-phase trial in healthy male athletes only, so results may not apply to others. The cannabinoid formulation may cause side effects or fail to show a protective effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Brain Concussion cannabis dependence Color Vision Defects Inflammation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Regina

    RECRUITING

    Regina, Saskatchewan, S4S-0A2, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.